Efficacy and Safety of TACE in Combination With Sorafenib for the Treatment of TACE-refractory Advanced Hepatocellular Carcinoma in Chinese Patients: A Retrospective Study
OncoTargets and Therapy- New Zealand
doi 10.2147/ott.s131022
Full Text
Abstract
Available in
Date
May 1, 2017
Authors
Publisher
Informa UK Limited